The insider selling is immaterial and likely driven by routine tax or diversification planning following equity grants. No actionable signal for traders; monitor for any material corporate events that might prompt larger-scale insider activity.
ONC drugs
ONC drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 16 $263.92entry
- T+1 · 5mo ago −0.47%α +0.78% · $262.68
- T+5 · 5mo ago +4.63%α +6.86% · $276.13
- T+20 · 4mo ago +16.16%α +15.96% · $306.56
- T+60 · 2mo ago +29.51%α +28.51% · $341.80
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Five BeOne Medicines insiders, including the CEO, sold a total of $1.98M in open-market shares over a one-week window. The selling is trivial relative to the $29.4B market cap (0.007%), and the cluster is accompanied by large equity grants to the same executives, suggesting routine compensation-related liquidity rather than a bearish signal.
Key Financial Metrics
Key Facts
- CEO John Oyler sold $1.03M worth of shares on 2026-06-08.
- Total open-market sales by 5 insiders: $1.98M.
- Total sales represent ~0.007% of ONC's $29.4B market cap.
- Multiple executives received large equity grants (non-cash) on the same date as some sales.
Financial Impact
Total insider sales of $1.98M, negligible relative to $29.4B market cap.
Risk Factors
- Insider selling could accelerate if executives perceive headwinds, but current levels are insignificant.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ONC-1781560626867 |
Track record
27 reports on ONC
3 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +12.55% at T+60 after the Aug 5, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $416.54 Now $411.29 −1.26% settles Nov 23
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $419.98 Now $411.29 −2.07% settles Nov 18
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $417.33 to $411.29 Now $411.29 −1.45% ▼ −1.45% +0.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $406.96 to $416.54 Now $411.29 +1.06% ▲ +2.35% −0.24% vs SPY
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $387.25 to $415.96 Now $411.29 +6.21% ▲ +7.41% +4.12% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $377.78 to $419.98 Now $411.29 +8.87% ▲ +11.17% +12.08% vs SPY
- Oct 2, 20266w ago Insider Cluster Bearish 5/10 Entry $361.65 to $350.40 Now $411.29 −13.73% ▲ +3.11% +3.53% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $368.08 to $365.27 Now $411.29 +11.74% ▼ −0.76% +0.42% vs SPY
- Sep 10, 20269w ago Insider Cluster Neutral 3/10 Entry $346.51 to $350.84 Now $411.29 +18.69% ▲ +1.25% +1.47% vs SPY
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $358.26 to $353.83 Now $411.29 +14.80% ▼ −1.24% −0.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers